|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| N-Isopropylaniline | CAS 768-52-5 | ||
| C6H5NHCH(CH3)2 | RTECS BY4190000 | ||
|
Synonyms & Trade Names N-IPA, Isopropylaniline, N-(1-Methylethyl)-benzenamine, N-Phenylisopropylamine |
DOT ID & Guide |
||
|
Exposure Limits |
NIOSH REL: TWA 2 ppm (10 mg/m3) [skin] | ||
| OSHA PEL�: none | |||
| IDLH N.D. | Conversion 1 ppm = 5.53 mg/m3 | ||
|
Physical Description Clear, yellowish liquid with a sweet, aromatic odor. |
|||
|
MW: 135.2 |
BP: 397°F |
FRZ: -58°F |
Sol: ? |
|
VP(77°F): 0.03 mmHg |
IP: ? |
|
Sp.Gr(60°F): 0.93 |
|
Fl.P(oc): 190°F |
UEL: ? |
LEL: ? |
|
| Class IIIB Combustible Liquid: Fl.P. at or above 200�F. | |||
|
Incompatibilities & Reactivities None reported |
|||
|
Measurement Methods OSHA 78 |
|
Personal Protection & Sanitation Skin: Prevent skin contact Eyes: Prevent eye contact Wash skin: When contaminated Remove: When wet or contaminated Change: No recommendation Provide: Quick drench |
First Aid (See procedures) Eye: Irrigate immediately Skin: Soap wash promptly Breathing: Respiratory support Swallow: Medical attention immediately |
| Respirator Recommendations To be added later | |
| Exposure Routes inhalation, skin absorption, ingestion, skin and/or eye contact | |
| Symptoms Irritation eyes, skin; headache, lassitude (weakness, exhaustion), dizziness; cyanosis; ataxia; dyspnea (breathing difficulty) on effort; tachycardia; methemoglobinemia | |
|
Target Organs
Eyes, skin, respiratory system, blood, cardiovascular system, liver, kidneys |
|
| See also: INTRODUCTION |